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Double-stranded RNA (dsRNA) has been isolated from Agaricus bisporus fruit bodies exhibiting a wide range of disease
symptoms. The symptoms which occurred singularly or in combination included; bare cropping areas on commercial
beds (primordia disruption), crop delay, premature veil opening, oﬀ- or brown-coloured mushrooms, sporophore
malformations and loss of crop yield. All symptoms were associated with loss of yield and/or product quality.
Collectively, these symptoms are described as mushroom virus X (MVX) disease. The dsRNA titre was much lower than
that previously encountered with the La France viral disease of mushrooms and a modiﬁed cellulose CF11 protocol was
used for their detection. A broad survey of cultivated mushrooms from the British industry identiﬁed dsRNA elements
ranging between 640 bp and 20.2 kbp; the majority have not previously been described in A. bisporus. 26 dsRNA
elements were identiﬁed with a maximum of 17, apparently non-encapsidated dsRNA elements, in any one sample. Three
dsRNAs (16.2, 9.4 and 2.4 kbp) were routinely found in mushrooms asymptomatic for MVX. Previously, La France
disease was eﬀectively contained and controlled by minimising the on-farm production and spread of basidiospores. Our
on-farm observations suggest that MVX could be spread by infected spores and/or mycelial fragments.
INTRODUCTION
Double-stranded RNA (dsRNA) elements have been
observed in many diﬀerent fungi. They can be either
encapsidated within a protein coat or non-encapsidated
where the dsRNAs reside as naked genetic elements
(Buck 1986, 1998). The dsRNAs may be beneﬁcial, det-
rimental or have no apparent eﬀect on the host fungus.
Encapsidated dsRNA mycoviruses were ﬁrst charac-
terised from diseased sporophores of the cultivated
mushroom Agaricus bisporus (Hollings 1962). Several
other viruses have also been identiﬁed in A. bisporus
including various sized spherical and bacilliform par-
ticles (Dieleman-vanZaayen&Temmink 1968,Hollings
1978, Revill, Davidson & Wright 1994). The most sev-
ere of these viruses, associated with La France or die-
back disease, comprises 35 nm particles and harbours
nine dsRNA molecules (Marino et al. 1976, Harmsen,
van Griensven &Wessels 1989, Goodin, Schlagnhaufer
& Romaine 1992). The La France virus caused exten-
sive crop losses to the Britishmushroom industry during
the 1960–70s. La France disease was eﬀectively con-
tained and controlled by adopting viral hygiene prac-
tices that minimised the on-farm production and
spread of basidiospores. The 35 nm dsRNA isometric
virus has been the subject of extensive epidemiological
studies (Schisler, Sinden & Sigel 1963, 1967, van
Zaayen 1979, Romaine, Ulhrich & Schlagnhaufer 1993)
and molecular characterisation (Harmsen et al. 1989,
1991, van der Lende, Harmsen &Wessels 1994, Goodin
et al. 1997). Occurrence of La France disease is now
extremely rare in British mushroom crops.
In recent years, a novel disease has become prevalent
in the British mushroom industry. During autumn
1996, a mushroom farm reported cropping problems
for which no satisfactory explanation could be found.
The symptom consisted of localised areas or patches of
mushroom bed where no primordia (pins) developed
and where no obvious cause could be identiﬁed (Gaze
1999). From 1996 to 2000, the number of aﬀected farms
and the range of symptoms increased. A few symptoms
were consistent with La France but commercial tests
for the 35 nm virus proved negative. Recently, the dis-
ease was associated with the presence of novel dsRNA
elements (Gaze et al. 2000). However, the dsRNAs did
not resemble those previously described in A. bisporus
and were substantially diﬀerent from those charac-
terised for La France disease.
The disease was termed ‘virus X’ as characteris-
ation of the dsRNAs was lacking (Gaze et al. 2000).* Corresponding author.
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This paper details the variety of symptoms associated
with the mushroom virus X (MVX) disease, describes
the extraction and characterisation of novel dsRNA
elements from A. bisporus fruit bodies, and indicates
that utilisation of appropriate viral hygiene measures
on-farm can reduce the impact of MVX.
MATERIALS AND METHODS
MVX symptoms and mushroom samples
Mushroom farms experiencing MVX were visited in
order to obtain pictures and details of disease symp-
toms. In Oct. 2000–May 2001, 320 mushroom samples
(both ‘healthy’ and diseased) were received from farms
and analysed for the presence of dsRNAs. Prior to
storage at x20 xC, 150 g samples of fruit bodies were
broken into small pieces. To increase the available
biomass during subsequent dsRNA extractions, fruit
body tissues were lyophilised for 3–4 d.
Extraction and electrophoresis of dsRNA
RNAs were isolated from freeze-dried fruit bodies
using a modiﬁcation of earlier protocols (Wach, Sris-
kantha & Romaine 1987, Romaine & Schlagnhaufer
1993, Goodin et al. 1997). All buﬀers and reagents
were prepared using dimethylpyrocarbonate (DMPC)
treated water (van Miltenburg et al. 1995). A 10 g dry
weight sample was ground to a ﬁne powder under
liquid nitrogen using a sterile mortar and pestle. The
powder was added to 60 ml of 2r STE buﬀer (Wach
et al. 1987) and 1% w/v SDS in a centrifuge tube and
mixed with a sterile glass rod to form an homogeneous
paste. The mixture was gently extracted using 0.5 vols
each of saturated phenol pH 4.5 and chloroform/
isoamyl alcohol (24:1) and centrifuged at 2500 g for
20 min. Using a pipette, the aqueous phase was trans-
ferred to a clean centrifuge tube and then centrifuged at
8000 g for 10 min to minimise contaminating phenol
and/or particulate matter. Absolute ethanol was added
to the puriﬁed aqueous phase to a ﬁnal concentration
15% v/v and dsRNAs were recovered by the addition
of 1.5 g ﬁbrous cellulose powder CF11 (The Labsales
Co., Cambridge). The preparation was held on ice for
30 min with mixing every 10 min and then centrifuged
at 8000 g for 10 min. The CF11-dsRNA complex was
resuspended in 15 ml STE buﬀer with 15% v/v ethanol
(Wach et al. 1987) and centrifuged at 8000 g for 10 min;
these washes were repeated seven times to remove
DNA and single-stranded RNA. The dsRNAs were
solubilised by the addition of 10 ml STE buﬀer (with-
out ethanol) and centrifugation at 8000 g for 10 min.
To eliminate the CF11, the supernatant was ﬁltered
through glass wool equilibrated with STE. Nucleic
acids were precipitated overnight atx20 x using 2 vols
ethanol, 0.1 vol 3 M pH 5.2 sodium acetate and
centrifugation at 8000 g for 10 min. The pellet was
washed with 70% v/v ethanol and resuspended in
500 ml water, precipitated again using ethanol and so-
dium acetate for 1–2 h at x70 x and centrifugation at
11 000 g for 15 min. The pellet was washed in 70% v/v
ethanol, air-dried for 20 min and ﬁnally resuspended in
32 ml water.
Where appropriate dsRNA preparations were
treated with RQ1 RNase-free DNase (Promega Cor-
poration, Madison, WI) and S1 nuclease (Promega)
according to themanufacturer’s recommendations. Fol-
lowing nuclease treatments, dsRNA was puriﬁed using
QIAquick PCR spin columns (Qiagen, Crawley) and
eluted in 30 ml water. The double-stranded integrity of
RNA products was conﬁrmed using RNase nuclease
treatments at diﬀerential salt concentrations (van der
Lende et al. 1994).
Samples were analysed electrophoretically using
0.7% w/v agarose, ethidium bromide and TAE
buﬀer (Sambrook, Fritsch & Maniatis 1989). Gel im-
ages were captured using Grabber software v. 2.00
(Phoretix International, Newcastle-upon-Tyne). Mol-
ecular weights were determined from migration rates
using Phoretix 1D Gel Analysis package v. 4.01
(Phoretix International) and various markers : marker
III from Roche Diagnostics (Lewes), and a 100 bp lad-
der (Invitrogen, Paisley). The higher molecular weight
dsRNA bands were sized using 0.4% w/v agarose and
a high molecular weight marker (Invitrogen).
On-farm observations
Regular contact with a number of farms since the onset
of MVX disease enabled detailed case histories to be
established. This was done in conjunction with regular
analysis of fruit body samples for the presence of MVX
dsRNAs. Some farms have succeeded in becoming
relatively free of MVX, while others have continued
to experience symptoms. Three contrasting sites were
chosen to illustrate as many facets of disease epidemi-
ology as possible. Because MVX disease is associated
with mushroom production, there is a need to describe
some industry practices in this manuscript. Expla-
nations of mushroom production terminology can be
found in Fletcher, White & Gaze (1989) and van
Griensven (1988).
RESULTS
Symptoms of MVX disease
Mushroom farms suﬀering from MVX reported a wide
variety of symptoms, which could be grouped into ﬁve
major categories as follows: pinning disruption and
associated crop delay, premature opening, oﬀ- or
brown-coloured mushrooms, malformations, and loss
of yield (Fig. 1a–h). Only oﬀ- or brown-coloured mush-
rooms were speciﬁc to MVX, the remaining symp-
toms can occur as a result of several other disorders,
including La France disease. Consequently, positive
conﬁrmation of novel dsRNAs was needed before
symptoms could be ascribed to MVX disease.
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Pinning disruption and crop delay
Mushroom pins formed normally on the beds, but their
subsequent development and growth was delayed by
one to several days, resulting in crop delay. Either the
whole or a small area of bed could be aﬀected (Fig. 1a).
In other cases, large or small areas of bare, non-
productive bed or ‘patches’ occurred where pins failed
to develop (Fig. 1b). This easily recognisable symptom
led to the use of the descriptor ‘patch’ disease. These
non-productive areas diﬀered in size and shape. They
ranged between being circular, forming swirls down the
length of a bed, to covering large irregular or geometri-
cal swathes of the bed. Frequently, non-productive
areas would grade into late developing pins and then
into apparently healthy mushrooms (Fig. 1c). Mush-
rooms sampled from asymptomatic beds/trays within
an aﬀected house usually contained the same dsRNAs
as those from the aﬀected location. In many cases,
mushrooms eventually developed in the bare areas,
Fig. 1.MVX symptomology in Agaricus bisporus : (a) area of mushroom bed showing pin suppression around a group of
normal mushrooms; in MVX-free production, beds would be uniformly covered with mushrooms; (b) bare area in
mushroom tray with no pins developing; (c) gradation in pin development from no pins on left to fully developed
mushrooms on right ; (d) premature opening of mushrooms; (e) oﬀ coloured ‘brown’ mushrooms from a white strain;
(f) ‘brown’ mushroom with thickened stipe on right, compared with normal white mushroom; and (g–h) malformed and
misshapen fruit bodies.
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but were out of synchronisation with the rest of the
crop.
Premature opening
Mushrooms growing on the beds would appear nor-
mal. Once picked and turned over however, it became
apparent that the veils had opened prematurely,
resulting in a loss of quality and downgrading of the
commercial product (Fig. 1d). In the worst cases, fruit
body veils were completely lacking. This symptom
often appeared only in the second ﬂush.
Oﬀ- or brown-coloured mushrooms
On some sites, the only symptom to be observed was
the presence of oﬀ-coloured or brown mushrooms
throughout a crop spawned with a white strain (Fig.
1e–f). The brown symptom could range from only a
few mushrooms on a bed, to ca 40% of a total crop.
MVX dsRNAs were also found in apparently ‘normal ’
mushrooms from within the same crop; some of these
mushrooms would discolour rapidly in storage, lead-
ing to the downgrading or rejection of product. The
brown-coloured symptom is the only one unique to
MVX, but it does not occur in all diseased crops.
Sporophore malformations and loss of yield
In cases where symptoms and yield losses were very
severe, mushrooms were often malformed and looked
similar to La France disease (Fig. 1g–h). Where symp-
toms were most severe, yield losses were as high as
50–80%.
DsRNA proﬁles
Mushrooms exhibiting the diﬀerent symptoms of MVX
invariably harboured a variety of dsRNA elements.
Using agarose electrophoresis, up to 26 diﬀerent
dsRNA bands were detectable (Fig. 2), ranging be-
tween 640 bp and 20.2 kbp. Three dsRNAs (MVX16.2a,
MVX9.4a and MVX2.4a) were routinely found in mush-
room samples asymptomatic for MVX and occurred
at sites that have never exhibited the disease. The
remaining 23 MVX bands were always associated
with symptoms, or sites with a history of symptoms.
Four low molecular weight dsRNAs (MVX2.0, MVX1.8,
MVX0.8, MVX0.6) were regularly associated with the
occurrence of the brown symptom.With this exception,
there was no obvious correlation between the pres-
ence of diﬀerent dsRNAs and the various symptoms
observed.
Fig. 2. Agarose electrophoresis of dsRNAs from Agaricus bisporus. Lanes 1–5, example dsRNA extractions from diﬀerent
MVX samples: lane 6, dsRNA extraction from sporophores asymptomatic for MVX; lane 7, dsRNA extraction from
sporophores infected with La France virus; lane M, molecular weight markers. Schematic indicates relative size of 26 dsRNA
elements observed during this study. Molecular weight (kbp) and frequency ( f ) data are indicated for each dsRNA element.
Location of asymptomatic dsRNAs are indicated by broken lines, and highlighted in the schematic with the suﬃx ‘a’ and
emboldened text.
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The maximum number of dsRNAs to occur in any
one sample was 17. Individual proﬁles varied consider-
ably between samples, although samples taken from
a single source at diﬀerent times usually gave similar
results (data not presented). Some dsRNA elements
occurred more often than others, and the frequency of
each dsRNA is summarised in Fig. 2. From the 320
samples tested in this study, 13% contained only
asymptomatic dsRNAs and were from sites classed as
either negative for MVX or recovering from the dis-
ease. A further 29%with up to two extra dsRNAs were
from sites thought to be recovering, while 58% of sam-
ples with three or more extra dsRNAs came from sites
with signiﬁcant MVX problems. The asymptomatic
dsRNA elements occurred most frequently (Fig. 2).
Only six other dsRNAs occurred in more than 20%
of samples. The remaining elements occurred with
frequencies ranging between 0.6 and 16%.
On-farm observations
Site 1
A large scale facility producing non-inoculated (bulk
phase II) and fully-colonised (bulk phase III) composts
in bulk tunnels for distribution to mushroom farms.
The phase II compost was either : (1) inoculated with
Agaricus bisporus mycelium (spawned phase II) in rela-
tively unprotected conditions prior to ‘blocking’ and
dispatch to mushroom farms; or (2) spawned in en-
closed conditions then ﬁlled into phase III tunnels for
incubation. The spawn-run phase III compost was
emptied from the opposite end of the tunnel, physically
isolated from the spawning operation. No mushrooms
were grown on site or in the vicinity. The most likely
source of dsRNA-containing material was the A. bis-
porus mycelium from the phase III compost. During
1999, MVX symptoms were apparent on farms receiv-
ing compost from this facility. They were, however,
more frequent and severe with the phase III compost.
Samples of both phase II and III composts were sam-
pled and grown in isolation on an uninfected site (HRI,
Wellesbourne). Mushrooms from the phase II compost
contained a total of eight dsRNA elements (MVX18.3,
16.2a, 9.4a, 8.6, 7.8, 7.0, 3.6, 2.4a), those from the phase
III compost contained nine dsRNAs (MVX18.3, 16.2a,
14.4, 9.4a, 8.6, 7.8, 7.0, 3.6, 2.4a) and the high intensity
of MVX14.4 was striking in agarose gels. We hypoth-
esised that there was no eﬀective physical virus barrier
between the phase III emptying hall (a source of
mycelium harbouringMVX) and the phase II spawning
areas. This would enable ‘ infected’ mycelial fragments
to be continually introduced into the freshly spawned
compost. During 2000, virus hygiene programmes
were reviewed at Site 1 and modiﬁed to prevent the
contamination of all phase II compost at spawning.
Throughout the next year, MVX dsRNAs, as well as
symptoms, continued to be detected in crops for a
period of time but gradually reduced in number and
intensity. In 2002, analyses of mushrooms from Site 1
composts indicated that only asymptomatic dsRNAs
were present at detectable levels. Crops that gave nor-
mal yields had no symptoms.
Site 2
This site produced both compost and mushrooms on
an isolated, self-suﬃcient, medium to large scale farm.
A ‘single zone’ system was employed in which phase I
compost was ﬁlled onto shelves in purpose built rooms.
All subsequent processes (pasteurisation, spawning,
spawn-running and cropping) took place in situ.
This site had a previous history of La France disease.
In 1998 non-productive areas of mushroom bed re-
duced yields to ca 40% of normal. Analysis of mush-
rooms conﬁrmed the presence of nine dsRNA elements
(MVX16.2a, 12.6, 9.4a, 8.6, 7.0, 5.9, 4.1, 3.6, 2.4a). It was
hypothesised that mushroom spores, were continually
passing from old to new crops, infecting both phase II
compost and spawn-running crops. Air ﬁltration to all
rooms was identiﬁed as inadequate and considerable
volumes of unﬁltered air were entering rooms through
poor door seals. The pasteurisation regime for raw
phase I compost was also ineﬀective, allowing mush-
room spores to survive. Eﬀective air ﬁltration was in-
stalled, the pasteurisation regime was improved, and all
door-seals were replaced. A dramatic increase in the
CO2 levels during spawn-running, conﬁrmed that un-
ﬁltered fresh air had been entering the rooms through
faulty door seals. Cropping returned to normal within
a few months of the modiﬁcations and analysis of
mushrooms in March 2000 indicated that dsRNAs
were reduced in number and intensity, to six (MVX16.2a,
10.2, 9.4a, 7.0, 3.6, 2.4a). By Nov. 2000, these were
reduced further to four (MVX16.2a, 9.4a, 2.4a, 1.1).
Site 3
A compact farm producing mushrooms on a large
scale. Raw phase I compost was delivered to the farm
and pasteurised in on-site tunnels to produce bulk
phase II compost. Spawned compost was ﬁlled into
phase III tunnels adjacent to the phase II pasteurising
tunnels. The spawn-run (bulk phase III) compost was
then emptied into the same hall used for spawning,
transported by trailer to the nearby cropping units and
ﬁlled onto shelves by conveyors. When all spawn-run
compost was emptied from the tunnels there followed
a thorough cleaning and disinfection regime to remove
potential virus-containing mushroom mycelium, in
preparation for another spawning operation the fol-
lowing week. Site 3 experienced a serious occurrence of
La France when it began production, but in later years
it had been free of viral problems. During March 2001
virtually all known MVX symptoms were observed on
Site 3 and 15 dsRNA elements (MVX20.1, 18.3, 16.2a,
14.4, 9.4a, 8.6, 7.0, 5.4, 4.8, 3.6, 2.4a, 2.0, 1.8, 0.8, 0.6)
were observed in mushroom samples. During a farm
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hygiene audit, multiple opportunities for spore and
mycelial contamination were identiﬁed. The design of
the site, with a common hall and equipment for spawn-
ing and emptying was considered a major weakness.
Revisions of hygiene procedures did not result in
a cessation of symptoms or a reduction in the num-
ber of dsRNAs elements. In Jan. 2002, mushroom
samples from the farm harboured 16 dsRNA elements
(MVX18.3, 16.2a, 9.4a, 8.6, 7.8, 7.0, 4.8, 3.6, 3.3. 2.4a,
2.0, 1.8, 1.6, 1.1, 0.8, 0.6). In July 2002, Site 3 ceased
production of bulk phase III and began buying in
spawned phase II compost to ﬁll directly onto shelves.
Crops returned to normal and mushrooms contained
only asymptomatic dsRNAs (MVX16.2a, 2.4a).
DISCUSSION
MVX disease of the commercial mushroom Agaricus
bisporus encompasses a diverse range of symptoms,
which can occur together or individually on a given
site. This relatively new disease (Gaze 1999) has had a
devastating eﬀect on the British mushroom industry.
More recently, mushrooms showing the browning
symptom have been observed elsewhere in Europe
(Anton Sonnenberg, pers. comm.). Four medium to
large British farms have closed as a consequence of
MVX. These farms accounted for about 10% of
total British mushroom production. During this time,
1999–2000, British mushroom production fell by 14%
(14 000 tonnes; DEFRA 2001).
To detect the MVX dsRNA elements, a relatively
large quantity of material was used and this represents
a divergence from the procedures used to detect the
La France dsRNAs, which are typically present in
higher titre. Early attempts to isolate dsRNA from
putative MVX samples using standardised protocols
(Wach et al. 1987, Romaine & Schlagnhaufer 1993)
indicated that any such nucleic acids were present in
very low titre (Peter Romaine, pers. comm.). During
this study, 26 dsRNA elements were detected in MVX
fruit body samples. The number and size of dsRNAs,
and the variation in their proﬁles suggests that MVX
may comprise a complex of more than one virus. Three
dsRNAs (MVX16.2a, MVX9.4a and MVX2.4a) were regu-
larly observed in mushrooms asymptomatic for MVX.
The remaining 23 dsRNAs were present in mushroom
samples from sites with MVX symptoms, or a history
of symptoms. Unlike La France, where nine major
dsRNAs consistently correlate with the disease, there
was no consistent banding pattern associated with
MVX disease. Some dsRNA elements occurred more
frequently than others ; four elements (MVX18.3, 7.0,
4.8, 3.6) appeared in 41–59% of samples while a fur-
ther ﬁve (MVX14.4, 8.6, 7.8, 2.0, 1.8) occurred in
10–26% of samples. The remaining dsRNAs occurred
infrequently.
The range of MVX symptoms encountered across
British sites has varied. Some sites had very speciﬁc
symptoms, for example only premature opening, or
only pin suppression and bare areas, while other sites
displayed a range of symptoms. Other than a tentative
association of four dsRNA elements (MVX2.0, MVX1.8,
MVX0.8, MVX0.6) with sporophore browning, clear re-
lationships between individual dsRNAs and speciﬁc
symptoms have not yet been deﬁned.
In mushrooms infected with La France, nine major
dsRNAs have been characterised (L1-3.6 kbp, L2-3.0
kbp, L3-2.8 kbp, L4-2.7 kbp, L5-2.5 kbp, M1-1.6 kbp,
M2-1.35 kbp, S1-0.86 kbp & S2-0.78 kbp; van der
Lende et al. 1994) but in general, these span a smaller
range than those of MVX (0.64–20.2 kbp). Another
dsRNA that often appears in La France samples
(L6-2.35 kbp; van der Lende et al. 1994) is also
found in healthy mushrooms and may be equivalent
to the MVX2.4a. Three asymptomatic dsRNA elements,
sized 2.4, 5.2 and >13 kbp, were previously found to
be associated with membrane vesicles (Romaine &
Schlagnhaufer 1989, Romaine, Schlagnhaufer &
Goodin 1994). Estimating the size of larger dsRNAs is
prone to considerable error and it’s possible that
MVX16.2a corresponds to the >13.1 kbp. It seems un-
likely however, that MVX9.4a relates to these previous
descriptions.
With La France virus it has not been possible to
conﬁrm Koch’s postulates. Similarly with MVX, in the
absence of Koch’s postulates, it is not possible to prove
that the dsRNA elements described here are the cause
of the MVX disease symptoms. With La France, ex-
periments have demonstrated transmission of the dis-
ease via anastomosis between infected and healthy
strains (Gandy & Hollings 1962, Hollings 1962) and it
has been shown that infected basidiospores can transfer
the disease (Schisler, Sinden & Sigel 1967). It appears
that MVX can also be transmitted between crops via
infected basidiospores. We have previously observed
that multispore axenic cultures prepared from MVX
diseased sporophores, and subsequent crops produced
from those multispore cultures can maintain the
dsRNA elements (Gaze et al. 2000). Our recent on-
farm observations and epidemiological experiments
suggest that infected spores and/or mycelial fragments
can spread MVX. Implementing on-farm hygiene
measures to reduce or eliminate the movement of
spores and/or mycelial fragments, can eﬀectively re-
duce the incidence of MVX, as determined by numbers
and intensity of symptoms and dsRNA elements. On
one farm (Site 3) with inherent design faults, elimin-
ation of contaminating mycelial fragments proved
intractable and MVX persisted until bulk phase III
production was stopped.
There is other evidence for higher molecular weight
dsRNAs inA. bisporus (e.g. Romaine et al. 1994). Over-
loading of agarose gels with La France dsRNAs can
reveal the ‘minor’ dsRNA elements ; XL1-LX4 of
about 15 kb, L0-6.5 kb, L7-2.0 kb, L8-1.9 kb and S3-
0.27 kb (Harmsen et al. 1989). In addition, extractions
from A. bisporus mycelial cultures revealed dsRNA
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ranging between 8.8 and 15 kb (Morten & Hicks 1992);
in some cases these bands were present in healthy cul-
tures. A few of the MVX dsRNAs are of similar size to
those of La France and it remains to be determined
whether such bands are dsRNA homologs. However,
immediate comparisons are confounded by limited se-
quence data for La France dsRNAs (M2, M1 & L3;
Harmsen et al. 1991) and the disparity in reported sizes
of such molecules (see above; Harmsen 1990).
DsRNA elements have been observed in other edible
species; in Flammulina velutipes two dsRNAs of 1.9
and 1.8 kbp and the presence of 50 nm particles were
implicated in the spontaneous browning of sporo-
phores (Magae & Hayashi 1999). The occurrence of
dsRNA elements in other fungi is well documented and
their presence is not always detrimental to the fungus
(Lemke & Nash 1974). There are, however, several ex-
amples of hypovirulence associated with dsRNA in
fungal plant pathogens (Day et al. 1977, Brasier 1983).
Not all dsRNA mycoviruses are encapsidated, for ex-
ample, the Cryphonectria parasitica hypovirulence
dsRNAs occur within membrane vesicles (Hansen et al.
1985). Hitherto, transmission electron microscopy of
MVX samples, has not revealed viral particles speci-
ﬁcally associated with the disease (Carol Everard &
Colin Clay, unpubl.), which suggests the dsRNAs are
non-encapsidated.
Mycoviral genomes can comprise multiple dsRNA
segments (Buck 1986). Alternatively, multiple dsRNA
molecules can result from subgenomic or defective
interfering particles (Tartaglia et al. 1986, Hiremath
et al. 1986). Indeed, the La France S3 dsRNA is an
internally deleted variant of the M2 dsRNA (Harmsen
et al. 1991). Our current research aims to gain a better
understanding of the epidemiology of MVX to assist
disease control strategies. We are cloning the dsRNA
elements to determine relationships between them and
to reveal the type of virus(es) present. MVX sequence
data will be used in the development of a PCR based
diagnostic for the mushroom industry.
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